Show simple item record

dc.contributor.authorDavies, Mary-Ann
dc.contributor.authorMoultrie, Harry
dc.contributor.authorEley, Brian
dc.contributor.authorRabie, Helena
dc.contributor.authorVan Cutsem, Gilles
dc.contributor.authorGiddy, Janet
dc.contributor.authorWood, Robin
dc.contributor.authorTechnau, Karl
dc.contributor.authorKeiser, Olivia
dc.contributor.authorEgger, Matthias
dc.contributor.authorBoulle, Andrew
dc.date.accessioned2012-12-11T23:46:39Z
dc.date.available2012-12-11T23:46:39Z
dc.date.issued2011-03-01
dc.identifier.citationJAIDS 2011; 56(3):270-8en
dc.identifier.issn1944-7884
dc.identifier.pmid21107266
dc.identifier.doi10.1097/QAI.0b013e3182060610
dc.identifier.urihttp://hdl.handle.net/10144/255412
dc.descriptionArticle approval pending
dc.description.abstractWith expanding pediatric antiretroviral therapy (ART) access, children will begin to experience treatment failure and require second-line therapy. We evaluated the probability and determinants of virologic failure and switching in children in South Africa.
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.relation.urlhttp://journals.lww.com/jaids/Abstract/2011/03010/Virologic_Failure_and_Second_Line_Antiretroviral.13.aspxen
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (JAIDS)en
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAntiretroviral Therapy, Highly Activeen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshChilden
dc.subject.meshChild, Preschoolen
dc.subject.meshDrug Monitoringen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHumansen
dc.subject.meshInfanten
dc.subject.meshMaleen
dc.subject.meshNevirapineen
dc.subject.meshPregnancyen
dc.subject.meshRitonaviren
dc.subject.meshSalvage Therapyen
dc.subject.meshSouth Africaen
dc.subject.meshTreatment Failureen
dc.subject.meshViral Loaden
dc.titleVirologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaborationen
dc.typeArticleen
dc.contributor.departmentSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; Enhancing Children's HIV Outcomes (Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, Soweto) and School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; Red Cross Children's Hospital and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa; Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa; Médecins Sans Frontières, Khayelitsha, South Africa and Khayelitsha ART Programme; McCord Hospital, Durban, South Africa; Gugulethu Community Health Centre and Desmond Tutu HIV Centre, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Empilweni Service and Research Unit, Rahima Moosa Mother and Child Hospital, University of the Witwatersrand, Johannesburg, South Africa; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerlanden
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromes (JAIDS)en
refterms.dateFOA2019-03-04T10:08:03Z
html.description.abstractWith expanding pediatric antiretroviral therapy (ART) access, children will begin to experience treatment failure and require second-line therapy. We evaluated the probability and determinants of virologic failure and switching in children in South Africa.


Files in this item

Thumbnail
Name:
Davies_Virologic-failure-and-s ...
Size:
174.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record